版本:
中国

BRIEF-Actinium Pharmaceuticals receives clearance from Health Canada to initiate pivotal phase 3 sierra trial of Iomab-B

May 10 Actinium Pharmaceuticals Inc

* Actinium Pharmaceuticals receives clearance from Health Canada to initiate pivotal phase 3 sierra trial of Iomab-B Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐